Inventor
CHRISTINA N. CARRIGAN
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties25%
PatentTitleYear
11,932,701Method for increasing the efficacy of cancer therapy by administering an anti-FOLR1 immunoconjugate202411,198,736Method for identifying an ovarian cancer in a subject likely to respond to anti-folate receptor 1 (FOLR1) antibody202111,135,305Methods for increasing efficacy of FOLR1 cancer therapy2021Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2021–2024Patents assigned to IMMUNOGEN INC (3)· patent assignee history
2021–2024Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| IMMUNOGEN INC | 3 | 2021–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2021–2024 |